I hold these stock.

DYOH (do your own homework.)

To-day there was a slight drop in price, but number of analysts are giving favourable reports.

What triggered my interest was better than expected results and if I am right looking at charts it shows an inverted head and shoulders. Hopefully a good sign. Also the current rate of Share price growth is about 90% pa over the last 5weeks. This is unlikely to continue indefinitely but SP could hit 850p over next few weeks.

To-day at close, there were some large buys of about 5million shares. 40million approx.

Another trigger for me was the following which should increase earnings.

Aviva to form JV in Taiwan with First FinancialAFX
LONDON (Thomson Financial) - Aviva PLC, the UK's largest insurer, said it has entered into a joint venture with First Financial Holding Co Ltd to sell insurance and pension products in Taiwan. The joint venture company, First-Aviva, will distribute long-term savings and pension products in Taiwan through an exclusive agreement with First Financial's flagship unit, First Commercial Bank. Aviva, which will have a 49 pct stake in the joint venture, added that the initial paid up capital of the new company will be 34 mln stg.First Commercial Bank is Taiwan's second largest bank network, with five mln retail customers, it added.TFN.newsdesk@thomson.comkkb/faj/slm




Date: Wednesday 25 Apr 2007
LONDON (ShareCast) - If the message gets home that Aviva will not bid for Prudential, the stock should rebound strongly, especially if Aviva can sustain its current impressive performance. There is still work to be done but, at 794.5p, the shares are a strong buy says the Independent.
Date: Tuesday 24 Apr 2007
LONDON (ShareCast) - Aviva stood out among the risers on a tough day for blue chip stocks. The life insurer posted an upbeat first quarter statement with brokers pleased with the numbers.



DYOH

Aviva getting rid of staff.

Exane BNP Paribas Outperform 0.00 303.30 379.00 379.00 Retains

Citigroup Buy 309.10 432.00 432.00 Retains

Result of AGM

Interim Management Statement

Mark Wilson, Group Chief Executive Officer, said:

``In the first quarter we have taken steps to deliver our investment thesis of cash flow and growth.

``Our operating expenses are now 10% lower and we are on track to deliver our cost savings target of £400 million.

``Our key measure of growth - value of new business - has increased by 18% driven by actions to improve profitability in UK Life and growth in our Asian business. In general insurance, our profitability was stable with a COR of 96% with a strong result in Canada.

``Net asset value has increased by 9% to 302 pence and our internal debt level has reduced by £300 million.

``Today's results demonstrate the first steps towards delivery. I am conscious of the challenges and do not want to set expectations at an unrealistic level. Progress so far has been satisfactory and there is a great deal more we need to do for our shareholders."

Gap being filled.

in the blue at last.,.

Long may it continue.

PE 8.2 Div yield about 5%. not too bad and projections seem OK.

Credit Suisse Outperform 341.75 435.00 435.00 Reiterates

JP Morgan Cazenove Overweight 341.75 393.00 393.00 Reiterates

Berenberg Hold 331.25 350.00 375.00 Retains

On the cusp of a golden cross.

Canaccord Genuity Hold 370.70 335.00 385.00 Reiterates

HY13 Part 1 of 5

Cash flow
Cash remittances to Group up 30% at £573 million1 (HY12: £441 million)
Operating capital generation £936 million1 (HY12: £906 million)
The interim dividend is 5.6 pence per share (HY12: 10.0 pence per share), consistent with guidance given at the full year 2012

Profit
Operating profit 5% higher at £1,008 million1 (HY12: £959 million)
IFRS profit after tax of £776 million (HY12: loss after tax of £624 million)

Expenses
Operating expenses 9% lower at £1,528 million2 (HY12: £1,675 million)
Restructuring costs 10% lower at £164 million1 (HY12: £182 million)

Value of new business
Value of new business up 17% to £401 million (HY12: £343 million)
Increase driven by UK Life, France, Poland, Turkey and Asia

Combined operating ratio
Combined operating ratio 96.2% (HY12: 95.5%)

Balance sheet
Intercompany loan reduced by £700 million to £5.1 billion
IFRS net asset value per share 281p (FY12: 278p)
MCEV net asset value per share 441p (FY12: 422p)
Pro forma3 economic capital surplus4 within our target range at £7.6 billion, 175% (FY12: £7.1 billion, 172%)
Sale of remaining shareholding in Delta Lloyd, disposal of businesses in Russia and Malaysia, and transfer of Aseval completed

Aviva turnaround advances as first half sales rise

LONDON | Thu Aug 8, 2013 7:03am BST
(Reuters) - Insurance group Aviva (AV.L) posted a 5 percent rise in operating profits as rising sales in key markets offset weakness in southern European operations.

In a half year earnings statement on Thursday, Aviva said the value of new business - its key measure of growth - grew 17 percent to 401 million pounds.

The performance was driven by the UK, France and Asia, thought sales fell sharply in Italy and Spain, Aviva said.

Morgan Stanley Overweight 391.80 403.00 403.00 Reiterates

Shore Capital Sell 391.80 - - Reiterates

Bank of America Merrill Lynch Buy 399.00 399.00 400.00 475.00 Upgrades

L&G go above 3% http://www.moneyam.com/action/news/showArticle?id=4649111

Nomura Buy 398.60 398.60 414.00 474.00 Retains

Canaccord Genuity Buy 401.05 398.70 385.00 460.00 Upgrades

Iowa insurance commissioner approves Athene's $1.55 billion buyout of Aviva USA

NEW YORK | Thu Aug 15, 2013 8:22pm BST
(Reuters) - The Iowa insurance commissioner approved Athene Holding Ltd's pending $1.55 billion (990.47 million pounds) purchase of British insurer Aviva Plc's (AV.L) U.S. annuity business, the state said on Thursday.

Aviva's U.S. operations are headquartered in Iowa, and approval from that state and New York were two regulatory hurdles for the deal, Apollo said in an August 8 earnings call.